Answer
Yes, Kisqali (ribociclib) can cause elevated liver enzymes (transaminases), requiring liver function monitoring and, depending on severity, treatment interruption, dose reduction or discontinuation.
Sources for this answer
- Kisqali film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 25Document updated
Sources checked